AOP Orphan is a European pioneer in the development, production and marketing of treatments for people with rare diseases also known as orphan diseases.
“Since 2007 our agile and motivated Hungarian team has been consolidating its competencies to deliver treatment options for patients with rare diseases! Mutual appreciation and commitment are the keys to our success!"
AOP Orphan is fully dedicated to pharmaceutical and clinical development as well as commercialization of drugs for more than 20 years already.
Our motivation at AOP Orphan is to help patients who suffer from rare diseases. We achieve this cooperating with stakeholders of the Hungarian health care system. Partnerships within pharmaceutical and health care industry are crucial for finding and providing solutions for patients, especially in the treatment of orphan diseases.
Hungary occupies a special position among many countries where AOP Orphan is represented. In this market, the company began its development in 2007. AOP Orphan Hungary is a team of six employees in the Marketing & Sales, and Medical for all three therapeutic divisions.